Loading...
XNAS
ACCD
Market cap575mUSD
Apr 07, Last price  
7.02USD
Name

Accolade Inc

Chart & Performance

D1W1MN
P/E
—
P/S
1.39
EPS
—
Div Yield, %
—
Shrs. gr., 5y
16.68%
Rev. gr., 5y
34.30%
Revenues
414m
+14.09%
76,828,00094,811,000132,507,000170,358,000310,021,000363,142,000414,292,000
Net income
-100m
L-78.29%
-61,286,000-56,496,000-51,365,000-50,652,000-123,124,000-459,650,000-99,805,000
CFO
-16m
L-60.28%
-38,285,000-16,548,000-34,247,000-25,232,000-62,350,000-40,705,000-16,169,000

Profile

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
URL
https://www.accolade.com
IPO date
Jul 02, 2020
Employees
2,370
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑022023‑022022‑022021‑022020‑022019‑022018‑02
Income
Revenues
414,292
14.09%
363,142
17.13%
Cost of revenue
483,581
480,574
Unusual Expense (Income)
NOPBT
(69,289)
(117,432)
NOPBT Margin
Operating Taxes
1,235
(3,624)
Tax Rate
NOPAT
(70,524)
(113,808)
Net income
(99,805)
-78.29%
(459,650)
273.32%
Dividends
Dividend yield
Proceeds from repurchase of equity
4,991
BB yield
-0.63%
Debt
Debt current
7,089
7,880
Long-term debt
267,287
343,985
Deferred revenue
121
154
Other long-term liabilities
156
203
Net debt
37,343
30,782
Cash flow
Cash from operating activities
(16,169)
(40,705)
CAPEX
(4,935)
(7,228)
Cash from investing activities
(63,629)
(7,228)
Cash from financing activities
(55,567)
3,163
FCF
(73,716)
(113,173)
Balance
Cash
237,033
321,083
Long term investments
Excess cash
216,318
302,926
Stockholders' equity
(1,054,138)
(954,287)
Invested Capital
1,741,528
1,730,128
ROIC
ROCE
EV
Common stock shares outstanding
74,907
71,280
Price
10.25
-7.74%
11.11
-38.21%
Market cap
767,796
-3.05%
791,919
-30.99%
EV
805,139
822,701
EBITDA
(24,125)
(71,055)
EV/EBITDA
Interest
255
Interest/NOPBT